| Oct 2, 2025 |
Oct 6, 2025 |
NeueHealth, Inc.
|
Director |
Sell |
26.3
|
-6,245,669
|
-32.62%
|
✗
|
$39.5K |
| Dec 23, 2024 |
Dec 23, 2024 |
Marker Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+554,250
|
51.73%
|
✗
|
$1.8M |
| Sep 16, 2024 |
Sep 17, 2024 |
MBX Biosciences, Inc.
|
10% Owner |
Buy |
100.0
|
+500,000
|
16.05%
|
✗
|
$8M |
| Apr 22, 2024 |
Apr 24, 2024 |
Korro Bio, Inc.
|
10% Owner |
Buy |
85.0
|
+17,857
|
1.66%
|
✗
|
$1000K |
| Jul 17, 2023 |
Jul 19, 2023 |
Savara Inc
|
10% Owner |
Buy |
85.0
|
+333,333
|
1.38%
|
✗
|
$1000K |
| Dec 20, 2022 |
Dec 22, 2022 |
Arcellx, Inc.
|
10% Owner |
Sell |
27.5
|
-1,999,717
|
-29.65%
|
✗
|
$5.5K |
| Jun 21, 2022 |
Jun 23, 2022 |
Arcellx, Inc.
|
10% Owner |
Buy |
93.8
|
+312,500
|
4.86%
|
✗
|
$5M |
| May 26, 2022 |
May 31, 2022 |
IonQ, Inc.
|
10% Owner |
Sell |
15.0
|
-2,922,966
|
-10.00%
|
✗
|
$17.1M |
| May 2, 2022 |
May 4, 2022 |
Robinhood Markets, Inc.
|
Director |
Sell |
26.3
|
-23,819,826
|
-49.99%
|
✗
|
$19.6K |
| Apr 11, 2022 |
Apr 13, 2022 |
Trevi Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+3,580,526
|
45.96%
|
✗
|
$6.8M |
| Feb 8, 2022 |
Feb 9, 2022 |
Arcellx, Inc.
|
10% Owner |
Buy |
100.0
|
+1,583,333
|
32.65%
|
✗
|
$23.7M |
| Jan 28, 2022 |
Feb 1, 2022 |
Robinhood Markets, Inc.
|
Director |
Sell |
26.3
|
-23,863,239
|
-33.37%
|
✗
|
$29.6K |
| Jun 28, 2021 |
Jun 30, 2021 |
NeueHealth, Inc.
|
Director |
Buy |
95.0
|
+1,944,444
|
2.78%
|
✗
|
$35M |
| Jun 28, 2021 |
Jun 30, 2021 |
Monte Rosa Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+1,050,000
|
15.81%
|
✗
|
$20M |
| Apr 13, 2021 |
Apr 15, 2021 |
OnKure Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+666,666
|
16.19%
|
✗
|
$10M |
| Mar 16, 2021 |
Mar 18, 2021 |
Marker Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+5,714,285
|
114.29%
|
✗
|
$10M |
| Jul 14, 2020 |
Jul 16, 2020 |
Nkarta, Inc.
|
10% Owner |
Buy |
100.0
|
+666,666
|
29.82%
|
✗
|
$12M |
| Apr 3, 2020 |
Apr 13, 2020 |
Trevi Therapeutics, Inc.
|
10% Owner |
Sell |
52.5
|
-564
|
-0.01%
|
✗
|
$1.5K |
| Jul 22, 2019 |
Jul 24, 2019 |
Mirum Pharmaceuticals, Inc.
|
10% Owner |
Buy |
100.0
|
+450,000
|
12.04%
|
✗
|
$6.8M |
| May 9, 2019 |
May 13, 2019 |
Trevi Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+2,500,000
|
128.96%
|
✗
|
$25M |